Clinical Trial Update: Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing muraglitazar to glimepiride in adults with type 2 diabetes not adequately controlled on metformin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glimepiride (glimepiride)
• Muraglitazar (muraglitazar)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED